UBS Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.68M | Buy |
245,817
+97,298
| +66% | +$1.22M | ﹤0.01% | 4699 |
|
|
2025
Q4 | $1.92M | Buy |
148,519
+66,544
| +81% | +$854K | ﹤0.01% | 5014 |
|
|
2025
Q3 | $1.06M | Sell |
81,975
-191,407
| -70% | -$2.56M | ﹤0.01% | 5531 |
|
|
2025
Q2 | $4.87M | Sell |
273,382
-130,157
| -32% | -$2.27M | ﹤0.01% | 3919 |
|
|
2025
Q1 | $7.19M | Sell |
403,539
-120,570
| -23% | -$2.74M | ﹤0.01% | 3404 |
|
|
2024
Q4 | $15.6M | Buy |
524,109
+369,139
| +238% | +$7.81M | ﹤0.01% | 2599 |
|
|
2024
Q3 | $2.42M | Sell |
154,970
-255,748
| -62% | -$4.64M | ﹤0.01% | 3815 |
|
|
2024
Q2 | $7.04M | Buy |
410,718
+65,054
| +19% | +$1.14M | ﹤0.01% | 2528 |
|
|
2024
Q1 | $5.4M | Buy |
345,664
+328,760
| +1,945% | +$4.84M | ﹤0.01% | 2891 |
|
|
2023
Q4 | $252K | Buy |
16,904
+12,193
| +259% | +$163K | ﹤0.01% | 5623 |
|
|
2023
Q3 | $76.1K | Sell |
4,711
-5,958
| -56% | -$172K | ﹤0.01% | 6022 |
|
|
2023
Q2 | $443K | Sell |
10,669
-3,655
| -26% | -$227K | ﹤0.01% | 4920 |
|
|
2023
Q1 | $861K | Sell |
14,324
-201
| -1% | -$16.1K | ﹤0.01% | 4241 |
|
|
2022
Q4 | $1.07M | Buy |
14,525
+4,622
| +47% | +$348K | ﹤0.01% | 4013 |
|
|
2022
Q3 | $753K | Buy |
9,903
+2,968
| +43% | +$232K | ﹤0.01% | 3987 |
|
|
2022
Q2 | $482K | Sell |
6,935
-1,945
| -22% | -$147K | ﹤0.01% | 4279 |
|
|
2022
Q1 | $736K | Sell |
8,880
-2,756
| -24% | -$203K | ﹤0.01% | 4393 |
|
|
2021
Q4 | $874K | Buy |
11,636
+1,969
| +20% | +$198K | ﹤0.01% | 4508 |
|
|
2021
Q3 | $1.12M | Sell |
9,667
-3,531
| -27% | -$534K | ﹤0.01% | 4096 |
|
|
2021
Q2 | $2.93M | Sell |
13,198
-42,185
| -76% | -$8.21M | ﹤0.01% | 3210 |
|
|
2021
Q1 | $7.32M | Buy |
55,383
+1,514
| +3% | +$239K | ﹤0.01% | 2234 |
|
|
2020
Q4 | $9.32M | Buy |
53,869
+26,007
| +93% | +$3.56M | ﹤0.01% | 1899 |
|
|
2020
Q3 | $3.1M | Buy |
27,862
+19,681
| +241% | +$1.57M | ﹤0.01% | 2647 |
|
|
2020
Q2 | $485K | Sell |
8,181
-55,435
| -87% | -$3.65M | ﹤0.01% | 4164 |
|
|
2020
Q1 | $4.28M | Sell |
63,616
-78,602
| -55% | -$6.21M | ﹤0.01% | 2062 |
|
|
2019
Q4 | $12M | Buy |
142,218
+62,517
| +78% | +$5.05M | 0.01% | 1794 |
|
|
2019
Q3 | $5.96M | Buy |
79,701
+40,953
| +106% | +$3.27M | ﹤0.01% | 2213 |
|
|
2019
Q2 | $2.45M | Buy |
38,748
+38,045
| +5,412% | +$1.93M | ﹤0.01% | 2964 |
|
|
2019
Q1 | $34K | Sell |
703
-1,324
| -65% | -$63.7K | ﹤0.01% | 5842 |
|
|
2018
Q4 | $68K | Sell |
2,027
-19,013
| -90% | -$695K | ﹤0.01% | 5850 |
|
|
2018
Q3 | $1.1M | Sell |
21,040
-6,195
| -23% | -$247K | ﹤0.01% | 3755 |
|
|
2018
Q2 | $853K | Buy |
27,235
+17,426
| +178% | +$485K | ﹤0.01% | 3906 |
|
|
2018
Q1 | $214K | Buy |
9,809
+7,762
| +379% | +$167K | ﹤0.01% | 4744 |
|
|
2017
Q4 | $41K | Sell |
2,047
-6,071
| -75% | -$117K | ﹤0.01% | 6004 |
|
|
2017
Q3 | $161K | Sell |
8,118
-498
| -6% | -$9.79K | ﹤0.01% | 5005 |
|
|
2017
Q2 | $149K | Buy |
8,616
+4,630
| +116% | +$59.8K | ﹤0.01% | 4933 |
|
|
2017
Q1 | $32K | Sell |
3,986
-3,745
| -48% | -$27K | ﹤0.01% | 5813 |
|
|
2016
Q4 | $61K | Buy |
7,731
+1,171
| +18% | +$9.42K | ﹤0.01% | 5668 |
|
|
2016
Q3 | $56K | Sell |
6,560
-2,441
| -27% | -$22.3K | ﹤0.01% | 5418 |
|
|
2016
Q2 | $105K | Buy |
9,001
+7,514
| +505% | +$94.1K | ﹤0.01% | 4993 |
|
|
2016
Q1 | $22K | Sell |
1,487
-10,727
| -88% | -$154K | ﹤0.01% | 6134 |
|
|
2015
Q4 | $273K | Buy |
+12,214
| New | +$292K | ﹤0.01% | 4432 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM